Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS–TEN overlap and potential drug–drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital
Rizky Abdulah,1 Tazkia F Suwandiman,1 Nadhira Handayani,1 Dika P Destiani,1 Auliya A Suwantika,1 Melisa I Barliana,2 Keri Lestari1 1Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, 2Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Ind...
Saved in:
Main Authors: | Abdulah R (Author), Suwandiman TF (Author), Nadhira H (Author), Destiani DP (Author), Suwantika AA (Author), Barliana MI (Author), Lestari K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Causative drugs and clinical outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN overlap in children
by: Gomathy Sethuraman, et al.
Published: (2012) -
Overlap SJS-TEN in a kid and management protocols
by: Sonali Mukherjee, et al.
Published: (2020) -
The Correlation of Neutrophil–Lymphocyte Ratio and Eosinophil Count with SCORTEN in SJS/TEN
by: Primisawitri PP, et al.
Published: (2022) -
From the Cochrane Library: Systemic Interventions for Steven-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS/TEN Overlap Syndrome
by: Gaurav Nitin Pathak, et al.
Published: (2024) -
Amifostine before radiotherapy: A rare cause of SJS-TEN overlap
by: Sujata Sengupta
Published: (2015)